Ionis Pharmaceuticals IONS Maximum Amount Of Payments Receivable For Additional Milestones
Maximum Amount Of Payments Receivable For Additional Milestones at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:MaximumAmountOfPaymentsReceivableForAdditionalMilestones.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's maximum amount of payments receivable for additional milestones.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's maximum amount of payments receivable for additional milestones?
- Ionis Pharmaceuticals (IONS) reported maximum amount of payments receivable for additional milestones of $625M in Q1 2023.
- What does maximum amount of payments receivable for additional milestones mean?
- The maximum potential future payments the company could receive from partners for hitting specific development or commercial goals.
- How do you interpret maximum amount of payments receivable for additional milestones?
- Higher values indicate greater potential for future non-dilutive revenue and pipeline success.
- How does maximum amount of payments receivable for additional milestones compare across companies?
- Common in biotech and pharmaceutical companies with heavy reliance on partnership-driven revenue models.